Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for colorectal cancer. This test aids in ...

Agilent (A) announced that its MMR IHC Panel pharmDx has received FDA approval as a companion diagnostic test for colorectal cancer. This test ...

TAKEAWAY: Overall, 43.9% patients underwent MMR/MSI testing, but testing rates increased more than threefold between 2012 and 2021 — from 22.7% to 71.5%.

Health officials in New Jersey are urging locals to stay up to date with the MMR vaccine and be on alert for symptoms after a ...

All it takes is one kid with measles to infect up to 18 others in their classroom. With school beginning soon, public health ...

Provide feedback by March 13. Post this Today, the groups open the public comment period for the guideline “MMR and MSI Testing in Patients Being Considered for Checkpoint Inhibitor Therapy.” ...

The Kansas Department of Health and Environment announced on Thursday that the measles outbreak affecting southwest Kansas ...

The measles outbreak has ended in southwest Kansas, but health officials say new cases could emerge this year.

Groundbreaking CAP Guideline Clarifies Biomarker Testing, Impacts Multiple Cancer Types August 03, 2022 04:18 PM Eastern Daylight Time ...